Showing results (131-140 of 202) with videos related to
Sort By:
Pageof 21
The American Journal of Pathology|May 11, 1999
Interferon (IFN)-beta gene transfer into TS/A adenocarcinoma cells and comparison with IFN-alpha: differential effects on tumorigenicity and host responseC Rozera, D Carlei, P L Lollini, et al.Oncogene|May 8, 2012
The Trop-2 signalling network in cancer growthE Guerra, M Trerotola, A L Aloisi, et al.Cancer Research|April 20, 2001
Interleukin 12-activated lymphocytes influence tumor genetic programsF Cavallo, E Quaglino, L Cifaldi, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 7, 2000
The combined action of IL-15 and IL-12 gene transfer can induce tumor cell rejection without T and NK cell involvementE Di Carlo, A Comes, S Basso, et al.The EMBO Journal|May 1, 1995
Lymphoproliferative disorder and imbalanced T-helper response in C/EBP beta-deficient miceI Screpanti, L Romani, P Musiani, et al.Molecular and Cellular Neurosciences|October 10, 2001
Role of STAT3 and PI 3-kinase/Akt in mediating the survival actions of cytokines on sensory neuronsT Alonzi, G Middleton, S Wyatt, et al.Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|March 1, 1994
Xenotransplantation rejection is antibody-mediated in both sensitized and nonsensitized recipientsI R Marino, S Celli, M Catena, et al.International Journal of Cancer|October 31, 2000
Salivary carcinoma in HER-2/neu transgenic male mice: an angiogenic switch is not required for tumor onset and progressionM G Diodoro, E Di Carlo, R Zappacosta, et al.The Journal of Investigative Dermatology|August 1, 1995
Tamoxifen and quercetin interact with type II estrogen binding sites and inhibit the growth of human melanoma cellsM Piantelli, N Maggiano, R Ricci, et al.Cancer|January 1, 1993
Type II estrogen binding sites and antiproliferative activity of quercetin in human meningiomasM Piantelli, A Rinelli, E Macrì, et al.Pageof 21